⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL11335832 | 0.86 | — | — | |
| Ether SCHEMBL27582247 | 0.86 | — | — | |
| Ether SCHEMBL6 | 0.85 | — | — | |
| Ether SCHEMBL9248046 | 0.85 | ALDH1A1 (0.47) | — | |
| Ether SCHEMBL8160191 | 0.85 | ALDH1A1 (0.47) | — | |
| Ether SCHEMBL9248674 | 0.85 | ALDH1A1 (0.47) | — | |
| Ether SCHEMBL21406 | 0.85 | ALDH1A1 (0.47) | — | |
| Ether SCHEMBL5070088 | 0.82 | — | — | |
| Ether SCHEMBL28235622 | 0.82 | — | — | |
| Ether SCHEMBL10719709 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105246866-B | The method of synthesis ingenol and its intermediate | 利奥实验室有限公司 | 2017-06-16 | — | — | CN | disclosed |
| US-9206346-B2 | Compositions and methods for diverting injected fluids to achieve improved hydrocarbon fluid recovery | NALCO COMPANY (US) | 2015-12-08 | — | — | US | disclosed |
| US-20150068748-A1 | COMPOSITIONS AND METHODS FOR DIVERTING INJECTED FLUIDS TO ACHIEVE IMPROVED HYDROCARBON FLUID RECOVERY | NALCO COMPANY (US) | 2015-03-12 | — | — | US | disclosed |
| US-8889603-B2 | Compositions and methods for diverting injected fluids to achieve improved hydrocarbon fluid recovery | NALCO COMPANY (US) | 2014-11-18 | — | — | US | disclosed |
| CN-103347525-A | Methods and compounds for preparing 3alpha-oxygen substituted steroids | HARBOR BIOSCIENCES INC | 2013-10-09 | — | — | CN | disclosed |
| WO-2009131881-A2 | COMPOSITIONS AND METHODS FOR DIVERTING INJECTED FLUIDS TO ACHIEVE IMPROVED HYDROCARBON FLUID RECOVERY | NALCO COMPANY (US) | 2009-10-29 | — | — | WO | disclosed |
| US-20090260819-A1 | COMPOSITIONS AND METHODS FOR DIVERTING INJECTED FLUIDS TO ACHIEVE IMPROVED HYDROCARBON FLUID RECOVERY | US SYNTHETIC CORPORATION | 2009-10-22 | — | — | US | disclosed |
| US-20040035417-A1 | Medicament dispenser | GLAXO GROUP LIMITED (GB) | 2004-02-26 | — | — | US | disclosed |
| EP-1349529-A2 | MEDICAMENT DISPENSER | GLAXO GROUP LIMITED (GB) | 2003-10-08 | — | — | EP | disclosed |
| US-20030183223-A1 | Metered dose inhaler | HAILEY ANDREW MARK (GB) | 2003-10-02 | — | — | US | disclosed |
| WO-2001064275-A1 | METERED DOSE INHALER | GLAXO GROUP LIMITED (GB) | 2001-09-07 | — | — | WO | disclosed |
| WO-2001005390-A2 | METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |
| WO-2001005393-A2 | METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |
| WO-2001005392-A2 | METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |
| WO-2001005391-A2 | METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |
| WO-2000042003-A1 | BENZENESULFONAMIDE DERIVATIVES AND THEIR USE AS MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000041505-A2 | ANTHRANILIC ACID DERIVATIVES | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042022-A1 | BENZOHETEROCYCLES AND THEIR USE AS MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000041994-A1 | 4-ARYLAMINO, 4-ARYLOXY, AND 4-ARYLTHIO DIARYLAMINES AND DERIVATIVES THEREOF AS SELECTIVE MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042029-A1 | 1-HETEROCYCLE SUBSTITUTED DIARYLAMINES | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |